Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

2965

Actual shortage: 237 (8%)
Anticipated shortage: 27 (1%)
Avoided shortage: 9 (0%)
Resolved: 2692 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

25 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2021-06-04 2021-06-14 140423
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2021-09-24 2021-10-05 146157
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2022-01-14 2022-02-07 152770
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2022-08-11 2022-10-20 166445
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2022-08-12 2022-10-20 166601
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-01-06 2023-03-02 180113
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2023-04-27 2023-06-23 190859
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2017-09-04 2018-07-31 20882
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2018-02-21 2018-05-01 40351
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2018-07-04 2018-12-28 54297
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2020-12-18 2021-01-19 130410
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2021-05-07 2021-06-14 138966
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2021-10-01 2021-10-01 146511
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2022-12-16 2023-03-02 178790
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2023-04-21 2023-06-23 189991
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2023-08-12 2023-11-17 201699
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Actual shortage 2024-02-09 2024-03-28 219165
APO-NAPROXEN SR TABLETS 750MG 750MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-08-13 2017-10-05 19015
APO-NEVIRAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2017-06-06 2017-08-30 12069
APO-NIFED PA 20MG TABLET (EXTENDED-RELEASE) Actual shortage 2017-08-13 2017-10-05 19018

Showing 1781 to 1800 of 2965

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-BRIMONIDINE 0.2% SOLUTION To be discontinued 2018-09-07 2018-09-07 60294
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2018-09-07 2018-12-28 60301
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-BROMAZEPAM 1.5MG TABLET To be discontinued 2018-09-07 2018-09-07 60304
APO-BROMAZEPAM 3MG TABLET Discontinued 2018-09-07 2019-06-12 60307
APO-BROMAZEPAM 6MG TABLET Discontinued 2018-09-07 2018-10-19 60310
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60313
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60316
APO-CANDESARTAN 4MG TABLET Discontinued 2018-09-07 2018-09-15 60319
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60322
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60325
APO-CANDESARTAN 32MG TABLET Discontinued 2018-09-07 2018-09-15 60328
APO-CANDESARTAN/HCTZ 25MG 32MG TABLET Discontinued 2018-02-26 2018-05-03 41011
APO-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Discontinued 2018-02-26 2018-02-26 41020
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-02-26 2018-02-26 41047
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60331
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60335
APO-CAPTO TAB 6.25MG 6.25MG TABLET Discontinued 2018-09-07 2019-06-12 60339
APO-CARVEDILOL 12.5MG TABLET To be discontinued 2024-01-26 2024-01-26 217493
APO-CARVEDILOL 3.125MG TABLET To be discontinued 2024-01-26 2024-01-26 217496

Showing 81 to 100 of 356